Clincosm LogoSign in Get a demo

furmonertinib

Showing 1 - 1 of 1
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Furmonertinib, EGFR-mutation, NSCLC Trial in Beijing (Furmonertinib)

Recruiting
  • Furmonertinib
  • +3 more
  • Beijing, China
    Ethics Committee
Jul 15, 2022